A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Novaferon in Patients with Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Novaferon (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 May 2012 Planned end date (31 Dec 2009) added as reported by Chinese Clinical Trial Register.
- 20 Dec 2011 New trial record